Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-25-003536
Filing Date
2025-08-12
Accepted
2025-08-12 18:00:55
Documents
5

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 16051
2 FORM OF SECURITIES PURCHASE AGREEMENT p25-1788exhibit99_1.htm EX-99.1 277943
3 CERTIFICATE OF DESIGNATION OF RIGHTS, PREFERENCES AND PRIVILEGES OF THE PREFERRE p25-1788exhibit99_2.htm EX-99.2 66266
4 NOTE PURCHASE AGREEMENT p25-1788exhibit99_3.htm EX-99.3 410029
5 COOPERATION AGREEMENT p25-1788exhibit99_4.htm EX-99.4 84755
  Complete submission text file 0000902664-25-003536.txt   856929
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Subject) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-39444 | Film No.: 251208296
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Filed by) CIK: 0001687509 (see all company filings)

EIN.: 300934659 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A